Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
Cibil Report
Get cibil report
My Account
Log In
Log into your account
Offers
Check out pre-approved offers now!
Languages
Chosen Language: English
Do Not Call
Do not call
En
Tejnaksh Healthcare Ltd. Share Price
N/A
1D
1M
3M
6M
1Y
5Y
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹14.40 |
|---|---|
| Day's Range | ₹14.39 - ₹14.49 |
| Open | ₹14.49 |
| 52 Week Range | ₹10.65 - ₹23.31 |
| Volume | 111 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 0.02 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 21.05 |
| TTM EPS (₹) | 0.68 |
| P/E Ratio | 18.31 |
| Book Value(₹) | 1.08 |
| PAT Margin (%) | 17.29 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 13.00 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 31.9 | 82.22 |
| Expenses | N/A | N/A |
| PBT | 9.66 | 24.32 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 5.55 | 18.12 |
About Tejnaksh Healthcare Ltd.
| Founded | 2008 |
|---|---|
| Managing Director | Ashish Vishwas Rawandale |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,51,194.94 | 1,876.45 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,82,992.80 | 6,854.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,49,926.25 | 4,497.90 | 3,102.00 - 3,102.00 |
| Apollo Hospitals Enterprise Ltd. | 1,16,446.16 | 8,238.00 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,13,051.69 | 1,406.00 | 1,165.70 - 1,165.70 |
| Dr. Reddy's Laboratories Ltd. | 1,10,333.30 | 1,321.00 | 1,148.40 - 1,148.40 |
| Mankind Pharma Ltd. | 1,06,668.90 | 2,527.85 | 1,909.70 - 1,909.70 |
| Max Healthcare Institute Ltd. | 1,04,750.23 | 1,099.85 | 903.00 - 903.00 |
| Zydus Lifesciences Ltd. | 1,04,743.93 | 1,033.50 | 835.50 - 835.50 |
| Lupin Ltd. | 1,04,400.67 | 2,286.80 | 1,836.80 - 1,836.80 |
No Records Found
Latest News
May
21
2026
Posted on May 21st 2026
IOL Chem & Pharma - Quaterly Results
A fair growth of 17.37% in the revenue at Rs. 6194.50 millions was reported in the March 2026 quarter as compared to Rs. 5277.80 millions during year-ago period.Handsome Net Profit growth of 68.18% reported above the corresponding previous quarter figure of Rs. 531.80 millions to Rs. 316.20 millions.Operating profit for the quarter ended March 2026 rose to 943.10 millions as compared to 674.60 millions of corresponding quarter ended March 2025.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 6194.50 | 5277.80 | 17.37 | 23190.60 | 20792.10 | 11.54 | 23190.60 | 20792.10 | 11.54 |
| Other Income | 17.40 | 45.20 | -61.50 | 212.80 | 224.00 | -5.00 | 212.80 | 224.00 | -5.00 |
| PBIDT | 943.10 | 674.60 | 39.80 | 2903.70 | 2245.70 | 29.30 | 2903.70 | 2245.70 | 29.30 |
| Interest | 32.10 | 40.30 | -20.35 | 145.50 | 147.60 | -1.42 | 145.50 | 147.60 | -1.42 |
| PBDT | 911.00 | 634.30 | 43.62 | 2646.10 | 2098.10 | 26.12 | 2646.10 | 2098.10 | 26.12 |
| Depreciation | 202.70 | 185.30 | 9.39 | 801.70 | 719.20 | 11.47 | 801.70 | 719.20 | 11.47 |
| PBT | 708.30 | 449.00 | 57.75 | 1844.40 | 1378.90 | 33.76 | 1844.40 | 1378.90 | 33.76 |
| TAX | 176.50 | 132.80 | 32.91 | 467.20 | 368.90 | 26.65 | 467.20 | 368.90 | 26.65 |
| Deferred Tax | 25.30 | 62.20 | -59.32 | 61.70 | 121.50 | -49.22 | 61.70 | 121.50 | -49.22 |
| PAT | 531.80 | 316.20 | 68.18 | 1377.20 | 1010.00 | 36.36 | 1377.20 | 1010.00 | 36.36 |
| Equity | 587.10 | 587.10 | 0.00 | 587.10 | 587.10 | 0.00 | 587.10 | 587.10 | 0.00 |
| PBIDTM(%) | 15.22 | 12.78 | 19.11 | 12.52 | 10.80 | 15.93 | 12.52 | 10.80 | 15.93 |
Read More
May
21
2026
Posted on May 21st 2026
Apollo Hospital Ent. - Quaterly Results
A fair growth of 17.50% in the revenue at Rs. 24385.00 millions was reported in the March 2026 quarter as compared to Rs. 20753.00 millions during year-ago period.A slim rise of 14.70% was recorded in the Net profit for the quarter ended March 2026 to Rs. 3824.00 millions From Rs. 3334.00 millions.Operating Profit saw a handsome growth to 6858.00 millions from 6129.00 millions in the quarter ended March 2026.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 24385.00 | 20753.00 | 17.50 | 93262.00 | 82021.00 | 13.71 | 93262.00 | 82021.00 | 13.71 |
| Other Income | 903.00 | 916.00 | -1.42 | 3718.00 | 3477.00 | 6.93 | 3718.00 | 3477.00 | 6.93 |
| PBIDT | 6858.00 | 6129.00 | 11.89 | 26998.00 | 23919.00 | 12.87 | 26998.00 | 23919.00 | 12.87 |
| Interest | 634.00 | 631.00 | 0.48 | 2417.00 | 2540.00 | -4.84 | 2417.00 | 2540.00 | -4.84 |
| PBDT | 6224.00 | 5498.00 | 13.20 | 24467.00 | 21379.00 | 14.44 | 24467.00 | 21379.00 | 14.44 |
| Depreciation | 1280.00 | 1298.00 | -1.39 | 5004.00 | 4494.00 | 11.35 | 5004.00 | 4494.00 | 11.35 |
| PBT | 4944.00 | 4200.00 | 17.71 | 19463.00 | 16885.00 | 15.27 | 19463.00 | 16885.00 | 15.27 |
| TAX | 1120.00 | 866.00 | 29.33 | 4537.00 | 3922.00 | 15.68 | 4537.00 | 3922.00 | 15.68 |
| Deferred Tax | -262.00 | -126.00 | 107.94 | -36.00 | -133.00 | -72.93 | -36.00 | -133.00 | -72.93 |
| PAT | 3824.00 | 3334.00 | 14.70 | 14926.00 | 12963.00 | 15.14 | 14926.00 | 12963.00 | 15.14 |
| Equity | 719.00 | 719.00 | 0.00 | 719.00 | 719.00 | 0.00 | 719.00 | 719.00 | 0.00 |
| PBIDTM(%) | 28.12 | 29.53 | -4.77 | 28.95 | 29.16 | -0.73 | 28.95 | 29.16 | -0.73 |
Read More
May
21
2026
Posted on May 21st 2026
Eris Lifesciences - Quaterly Results
The sales moved down -31.49% to Rs. 2773.10 millions for the March 2026 quarter as compared to Rs. 4047.70 millions during the corresponding quarter last year.The Net Loss for the quarter ended March 2026 is Rs. -86.00 millions as compared to Net Profit of Rs. 304.70 millions of corresponding quarter ended March 2025The company reported a degrowth in operating Profit to 487.50 millions from 1377.20 millions.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 2773.10 | 4047.70 | -31.49 | 18217.40 | 16977.50 | 7.30 | 18217.40 | 16977.50 | 7.30 |
| Other Income | 269.70 | 167.50 | 61.01 | 983.10 | 355.10 | 176.85 | 983.10 | 355.10 | 176.85 |
| PBIDT | 487.50 | 1377.20 | -64.60 | 7106.40 | 5220.60 | 36.12 | 7106.40 | 5220.60 | 36.12 |
| Interest | 427.00 | 531.60 | -19.68 | 1795.40 | 2202.40 | -18.48 | 1795.40 | 2202.40 | -18.48 |
| PBDT | 60.50 | 845.60 | -92.85 | 5164.30 | 3018.20 | 71.11 | 5164.30 | 3018.20 | 71.11 |
| Depreciation | 388.20 | 433.80 | -10.51 | 1543.80 | 1817.70 | -15.07 | 1543.80 | 1817.70 | -15.07 |
| PBT | -327.70 | 411.80 | -179.58 | 3620.50 | 1200.50 | 201.58 | 3620.50 | 1200.50 | 201.58 |
| TAX | -241.70 | 107.10 | -325.68 | 1180.00 | 426.60 | 176.61 | 1180.00 | 426.60 | 176.61 |
| Deferred Tax | -165.40 | 22.00 | -851.82 | 570.40 | 206.80 | 175.82 | 570.40 | 206.80 | 175.82 |
| PAT | -86.00 | 304.70 | -128.22 | 2440.50 | 773.90 | 215.35 | 2440.50 | 773.90 | 215.35 |
| Equity | 138.50 | 136.20 | 1.69 | 138.50 | 136.20 | 1.69 | 138.50 | 136.20 | 1.69 |
| PBIDTM(%) | 17.58 | 34.02 | -48.33 | 39.01 | 30.75 | 26.86 | 39.01 | 30.75 | 26.86 |
Read More
May
21
2026
Posted on May 21st 2026
Kaya - Quaterly Results
A minor change in the total revenue was seen in the March 2026 quarter. The total revenue for the quarter stood at Rs. 557.99 millions against Rs. 546.87 millions during year ago period.The Net Loss for the quarter ended March 2026 is Rs. -277.67 millions as compared to Net Loss of Rs. -69.72 millions of corresponding quarter ended March 2025Operating profit Margin for the quarter ended March 2026 slipped to -106.80% as compared to 103.46% of corresponding quarter ended March 2025
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 557.99 | 546.87 | 2.03 | 2224.76 | 2174.23 | 2.32 | 2224.76 | 2174.23 | 2.32 |
| Other Income | 20.00 | 44.50 | -55.06 | 86.82 | 170.54 | -49.09 | 86.82 | 170.54 | -49.09 |
| PBIDT | -106.80 | 103.46 | -203.23 | -150.43 | 417.88 | -136.00 | -150.43 | 417.88 | -136.00 |
| Interest | 92.03 | 78.69 | 16.95 | 356.23 | 306.58 | 16.19 | 356.23 | 306.58 | 16.19 |
| PBDT | -161.42 | 24.77 | -751.68 | -521.17 | 111.30 | -568.26 | -521.17 | 111.30 | -568.26 |
| Depreciation | 116.25 | 94.49 | 23.03 | 440.14 | 376.41 | 16.93 | 440.14 | 376.41 | 16.93 |
| PBT | -277.67 | -69.72 | 298.26 | -961.31 | -265.11 | 262.61 | -961.31 | -265.11 | 262.61 |
| TAX | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PAT | -277.67 | -69.72 | 298.26 | -961.31 | -265.11 | 262.61 | -961.31 | -265.11 | 262.61 |
| Equity | 151.88 | 130.98 | 15.96 | 151.88 | 130.98 | 15.96 | 151.88 | 130.98 | 15.96 |
| PBIDTM(%) | -19.14 | 18.92 | -201.17 | -6.76 | 19.22 | -135.18 | -6.76 | 19.22 | -135.18 |
Read More
May
21
2026
Posted on May 21st 2026
Looks Health Service - Quaterly Results
The sales is pegged at Rs. 1.24 millions for the March 2026 quarter. The mentioned figure indicates a decline of about -68.61% as against Rs. 3.95 millions during the year-ago period.Net Profit for the quarter ended March 2026 dipped to Rs. 0.08 millions from Rs. 1.88 millions in the corresponding previous quarter.A decline of 0.46 millions was observed in the OP in the quarter ended March 2026 from 2.44 millions on QoQ basis.
| (Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 1.24 | 3.95 | -68.61 | 3.88 | 3.95 | -1.77 | 3.88 | 3.95 | -1.77 |
| Other Income | 0.01 | 0.43 | -97.67 | 0.04 | 3.90 | -98.97 | 0.04 | 3.90 | -98.97 |
| PBIDT | 0.46 | 2.44 | -81.15 | 1.74 | 1.70 | 2.35 | 1.74 | 1.70 | 2.35 |
| Interest | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 |
| PBDT | 0.46 | 2.44 | -81.15 | 1.73 | 1.70 | 1.76 | 1.73 | 1.70 | 1.76 |
| Depreciation | 0.35 | 0.35 | 0.00 | 1.42 | 1.42 | 0.00 | 1.42 | 1.42 | 0.00 |
| PBT | 0.11 | 2.09 | -94.74 | 0.31 | 0.28 | 10.71 | 0.31 | 0.28 | 10.71 |
| TAX | 0.03 | 0.21 | -85.71 | 0.08 | 0.05 | 60.00 | 0.08 | 0.05 | 60.00 |
| Deferred Tax | -0.06 | -0.06 | 0.00 | -0.24 | -0.22 | 9.09 | -0.24 | -0.22 | 9.09 |
| PAT | 0.08 | 1.88 | -95.74 | 0.23 | 0.23 | 0.00 | 0.23 | 0.23 | 0.00 |
| Equity | 105.00 | 105.00 | 0.00 | 105.00 | 105.00 | 0.00 | 105.00 | 105.00 | 0.00 |
| PBIDTM(%) | 37.10 | 61.77 | -39.95 | 44.85 | 43.04 | 4.20 | 44.85 | 43.04 | 4.20 |
Read More
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Tejnaksh Healthcare Ltd. is ₹14.40 as of 2026-05-21.
The market capitalisation of Tejnaksh Healthcare Ltd. is ₹28.95 as of 2026-05-20.
The 1-year return of Tejnaksh Healthcare Ltd. is -7.24% as of 2025-05-20.
The P/E ratio of Tejnaksh Healthcare Ltd. is 18.31 as of 2026-05-21.
The 52-week high and low of Tejnaksh Healthcare Ltd. are ₹23.31 and ₹10.65, respectively, as of 2026-05-21.
View More
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
Home
Shopping
Loan Offers
My Accounts
Explore
